Microchimerism after pancreas and kidney transplantation--a review
- PMID: 22210434
- DOI: 10.12659/aot.882231
Microchimerism after pancreas and kidney transplantation--a review
Abstract
The main cause of a negative response to grafting is immune rejection connected with a reaction to the donor's antigens. The process of rejecting transplanted organs is a whole-body process. The reaction of the organism begins when the donor's antigens reach the recipient's lymphatic organs via blood or lymph. The donor's genetic material (DNA) is detected in the recipient's blood and lymphoid tissues even a few months after transplant rejection. Microchimerism occurs when in an individual patient the cells and genetic material from both the donor and recipient are present and the cell count of one of these is overrepresented. Such situations can occur after blood transfusions, grafts or pregnancies. It is suggested that this phenomenon could have an influence on tolerance, prolonged graft survival or the rejection process. The results of many experiments are thus far equivocal; therefore further research is needed elucidate the process and mechanisms of graft rejection and its molecular aspects.
Similar articles
-
Microchimerism and rejection in clinical transplantation.Lancet. 1997 May 10;349(9062):1358-60. doi: 10.1016/s0140-6736(96)09105-2. Lancet. 1997. PMID: 9149698
-
[New trends in immunosuppressive therapy in patients with kidney transplants].Srp Arh Celok Lek. 1997 Mar-Apr;125(3-4):99-105. Srp Arh Celok Lek. 1997. PMID: 9221526 Review. Serbian.
-
Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation.Transpl Immunol. 2011 Jul;25(1):1-6. doi: 10.1016/j.trim.2011.05.002. Epub 2011 May 17. Transpl Immunol. 2011. PMID: 21616149 Clinical Trial.
-
Microchimerism in female renal transplant recipients from male donors.Int J Urol. 1996 Jan;3(1 Suppl):S114-9. doi: 10.1111/j.1442-2042.1996.tb00328.x. Int J Urol. 1996. PMID: 24449957
-
A new concept of accommodation in ABO-incompatible kidney transplantation.Clin Transplant. 2005;19 Suppl 14:76-85. doi: 10.1111/j.1399-0012.2005.00392.x. Clin Transplant. 2005. PMID: 15955174 Review.
Cited by
-
Overcoming bioethical, legal, and hereditary barriers to mitochondrial replacement therapy in the USA.J Assist Reprod Genet. 2019 Mar;36(3):383-393. doi: 10.1007/s10815-018-1370-7. Epub 2018 Dec 15. J Assist Reprod Genet. 2019. PMID: 30554395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical